Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Melani

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Oncology (Williston Park, N.Y.)|August 20, 2016
Molecular Monitoring of Cell-Free Circulating Tumor DNA in Non-Hodgkin LymphomaChristopher Melani, Mark Roschewski
Leukemia & Lymphoma|November 12, 2021
Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cureChristopher Melani, Wyndham H Wilson
Best Practice & Research. Clinical Haematology|September 15, 2018
Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNAChristopher Melani, Wyndham H Wilson, Mark Roschewski
British Journal of Haematology|March 14, 2018
What is the standard of care for primary mediastinal b-cell lymphoma; R-CHOP or DA-EPOCH-R?Christopher Melani, Wyndham H Wilson, Mark Roschewski
Haematologica|August 2, 2018
End-of-treatment and serial PET imaging has prognostic value and clinical utility in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R - Response to Adams <i>et al.</i>Christopher Melani, Mark Roschewski, Wyndham H Wilson
Hematological Oncology|June 13, 2019
Liquid biopsy in non-Hodgkin's lymphomaChristopher Melani, Wyndham H Wilson, Mark Roschewski
Blood|February 29, 2020
Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorderChristopher Melani, Elaine S Jaffe, Wyndham H Wilson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2022
Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?Rahul Lakhotia, Christopher Melani, Mark Roschewski, et al.
Blood Advances|June 24, 2026
Meta-analysis of survival by phased-variant ctDNA and PET response in large B-cell lymphomaMax J Gordon, Hyoyoung Choo-Wosoba, Gonca Ozcan, et al.
Leukemia & Lymphoma|October 17, 2017
Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomasJoseph Roswarski, Mark Roschewski, Andrea Lucas, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Oncology (Williston Park, N.Y.)|August 20, 2016
Molecular Monitoring of Cell-Free Circulating Tumor DNA in Non-Hodgkin LymphomaChristopher Melani, Mark Roschewski
Leukemia & Lymphoma|November 12, 2021
Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cureChristopher Melani, Wyndham H Wilson
Best Practice & Research. Clinical Haematology|September 15, 2018
Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNAChristopher Melani, Wyndham H Wilson, Mark Roschewski
British Journal of Haematology|March 14, 2018
What is the standard of care for primary mediastinal b-cell lymphoma; R-CHOP or DA-EPOCH-R?Christopher Melani, Wyndham H Wilson, Mark Roschewski
Haematologica|August 2, 2018
End-of-treatment and serial PET imaging has prognostic value and clinical utility in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R - Response to Adams <i>et al.</i>Christopher Melani, Mark Roschewski, Wyndham H Wilson
Hematological Oncology|June 13, 2019
Liquid biopsy in non-Hodgkin's lymphomaChristopher Melani, Wyndham H Wilson, Mark Roschewski
Blood|February 29, 2020
Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorderChristopher Melani, Elaine S Jaffe, Wyndham H Wilson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2022
Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?Rahul Lakhotia, Christopher Melani, Mark Roschewski, et al.
Blood Advances|June 24, 2026
Meta-analysis of survival by phased-variant ctDNA and PET response in large B-cell lymphomaMax J Gordon, Hyoyoung Choo-Wosoba, Gonca Ozcan, et al.
Leukemia & Lymphoma|October 17, 2017
Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomasJoseph Roswarski, Mark Roschewski, Andrea Lucas, et al.
Pageof 3